BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6915722)

  • 1. Noncontact detection of experimental amelanotic ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine.
    Bockslaff H; Spitznas M; Hahn I; Kloster G
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(4):255-66. PubMed ID: 6915722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noncontact detection of ocular melanoma with L-3-123I-iodo-alpha-methyltyrosine: first clinical results.
    Bockslaff H; Kloster G; Dausch D; Schad K; Hundeshagen H
    Graefes Arch Clin Exp Ophthalmol; 1982; 219(3):149-54. PubMed ID: 7173627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-3-123I-alpha-methyltyrosine for melanoma detection: a comparative evaluation.
    Kloster G; Bockslaff H
    Int J Nucl Med Biol; 1982; 9(4):259-69. PubMed ID: 6225742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of 123I-5-iodo-2-thiouracil, a possible radiopharmaceutical for noninvasive detection of ocular melanoma, in melanotic and amelanotic melanomas in hamsters.
    Franken NA; Van Langevelde A; Journée-De Korver JG; Bakker CN; Feitsma RI; Van Delft JL; Oosterhuis JA; Pauwels EK
    Nucl Med Commun; 1985 Oct; 6(10):657-63. PubMed ID: 4088550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential radiopharmaceuticals for the detection of ocular melanoma. Part I. 5-iodo-2-thiouracil derivatives.
    van Langevelde A; Bakker CN; Broxterman HJ; Journée-de Korver JG; Kaspersen FM; Oosterhuis JA; Pauwels EK
    Eur J Nucl Med; 1983; 8(2):45-51. PubMed ID: 6840126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintimetric detection of choroidal malignant melanoma with [123I]-5-iodo-2-thiouracil.
    Franken NA; van Delft JL; van Langevelde A; Bleeker JC; de Wolff-Rouendaal D; van Best JA; Bouwhuis-Hoogerwerf ML; Oosterhuis JA; Pauwels EK
    Ophthalmologica; 1986; 193(4):248-54. PubMed ID: 3587880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Noncontact detection of intraocular lesions by means of a gamma scintillation camera].
    Bockslaff H; Dausch D; Bornemann H; Stöppler L; Hundeshagen H
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Sep; 211(3):187-203. PubMed ID: 316287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of ocular melanoma with 4-(3-dimethylaminopropylamino)-7-[123I]-iodoquinoline.
    Lambrecht RM; Packer S; Wolf AP; Lloyd D; Atkins HL
    J Nucl Med; 1984 Jul; 25(7):800-4. PubMed ID: 6737079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential radiopharmaceuticals for the detection of ocular melanoma. Part II. Iodoquinoline derivatives and 67Ga-citrate.
    van Langevelde A; Bakker CN; Boer H; Ilmer TA; Journée-de Korver JA; Kaspersen FM; Noach EL; Oosterhuis JA; Pauwels EK
    Eur J Nucl Med; 1986; 12(2):96-104. PubMed ID: 3460807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.
    Bubeck B; Eisenhut M; Heimke U; zum Winkel K
    Eur J Nucl Med; 1981; 6(5):227-33. PubMed ID: 6788553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
    Steinert H; Böni R; Huch-Böni RA; Capaul R; von Schulthess GK; Westera G
    Nuklearmedizin; 1997 Mar; 36(2):36-41. PubMed ID: 9148271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of ocular melanoma with N-isopropyl-p-[123I]-iodoamphetamine.
    Ono S; Fukunaga M; Otsuka N; Nagai K; Morita K; Furukawa T; Muranaka A; Yanagimoto S; Tomomitsu T; Tabuchi A
    J Nucl Med; 1988 Aug; 29(8):1448-50. PubMed ID: 3404259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal isotopes used as radioactive indicators of ocular melanoma.
    Packer S; Lambrecht RM; Christman DR; Ansari AN; Wolf AP; Atkins HL
    Am J Ophthalmol; 1977 Jan; 83(1):80-94. PubMed ID: 835671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium-67 citrate in the detection of ocular malignant melanoma.
    Camps JA; Oosterhuis JA; van Langevelde A; Pauwels EK; Stijnen T
    Nucl Med Commun; 1987 Jan; 8(1):62. PubMed ID: 3472128
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical characterization of experimental Greene melanoma.
    Wollensak G
    Ophthalmic Res; 1992; 24(1):55-8. PubMed ID: 1608593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ocular tumors with technetium-99m-MIBI: planar pinhole technique or SPECT?
    Alonso O; Núñez M; Cánepa J; Guisoli P; Mut F; Lago G; Touya E
    J Nucl Med Technol; 2000 Jun; 28(2):85-7. PubMed ID: 10824618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular radioimmunoscintigraphy: sensitivity and practical considerations.
    Bomanji J; Nimmon CC; Hungerford JL; Solanki K; Granowska M; Britton KE
    J Nucl Med; 1988 Jun; 29(6):1031-7. PubMed ID: 3373313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular malignant melanoma detected with Tc-99m MIBI and Tc-99m HMPAO.
    Sarikaya I; Ibiş E; Günalp I; Aras G
    Clin Nucl Med; 1999 Aug; 24(8):624-5. PubMed ID: 10439197
    [No Abstract]   [Full Text] [Related]  

  • 19. False-positive phosphorus 32 uptake tests in the diagnosis of ocular melanoma.
    Zakov ZN; Cook SA; Albert DM; Weichselbaum RR
    Int Ophthalmol Clin; 1980; 20(2):117-21. PubMed ID: 6995382
    [No Abstract]   [Full Text] [Related]  

  • 20. Ocular melanoma.
    Schaling DF; Oosterhuis JA; Pauwels EK
    Br J Ophthalmol; 1990 Apr; 74(4):254-5. PubMed ID: 2337558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.